个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共10条记录   Safety profile of esomeprazole - Results of a prescription-event monitoring study of 11595 patients in England [作者：Davies, M; Wilton, LV; Shakir, SAW,期刊：Drug safety, 页码：313-323 , 文章类型： Article，,卷期：2008年31-4] Objective: Esomeprazole, the S-isomer of omeprazole, was launched in the UK in September 2000. The first proton pump inhibitor, omeprazole, has been marketed in the UK for over 10 years. However, the adverse event databa... Adequacy of patient information on adverse effects - An assessment of patient information leaflets in the UK [作者：Carrigan, N; Raynor, DK; Knapp, P,期刊：Drug safety, 页码：305-312 , 文章类型： Article，,卷期：2008年31-4] Background: One of the most important categories of information that patients want to know about the drug they are taking is the likelihood or probability of adverse effects. All patients should receive such information ... Hepatic effects of lovastatin exposure in patients with liver disease - A retrospective cohort study [作者：Avins, AL; Manos, MM; Ackerson, L; Zhao, W; Murphy, R; Levin, TR; Watson, DJ; Hwang, PMT; Replogle, A; Levine, JG,期刊：Drug safety, 页码：325-334 , 文章类型： Article，,卷期：2008年31-4] Background: Little is known about the potential adverse hepatic effects of HMG-CoA reductase inhibitors (statins) in patients with existing liver disease; therefore, we examined the risk of liver toxicity with lovastatin... Improving the reporting of adverse drug reactions - A cluster-randomized trial among pharmacists in Portugal [作者：Herdeiro, MT; Polonia, J; Gestal-Otero, JJ; Figueiras, A,期刊：Drug safety, 页码：335-344 , 文章类型： Article，,卷期：2008年31-4] Background: Adverse drug reaction (ADR) reporting systems are the basic component for comprehensive postmarketing surveillance of the risk of drug-induced adverse effects. The aim of this study was to evaluate the effect... Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder [作者：Bangs, ME; Jin, L; Zhang, S; Desaiah, D; Allen, AJ; Read, HA; Regev, A; Wernicke, JF,期刊：Drug safety, 页码：345-354 , 文章类型： Article，,卷期：2008年31-4] Objective: This study describes and assesses potential hepatobiliary events related to atomoxetine therapy, as reported in clinical trials and as spontaneous adverse event reports post-launch in 2002.Methods: Case report... Publishing histories of adverse reactions to medicaments - Anecdotally the PHARMA guidelines for reporting suspected adverse drug reactions [作者：Aronson, JK,期刊：Drug safety, 页码：355-356 , 文章类型： Letter，,卷期：2008年31-4] Publishing histories of adverse reactions to medicaments - Anecdotally the PHARMA guidelines for reporting suspected adverse drug reactions - Reply [作者：Kelly, W; Moore, N; Goldsmith, DI; Jones, JK; Trenque, T; van Puijenbroek, E,期刊：Drug safety, 页码：356-357 , 文章类型： Letter，,卷期：2008年31-4] A benefit-risk review of systemic halemostatic agents - Part 2: In excessive or heavy menstrual bleeding [作者：Fraser, IS; Porte, RJ; Kouides, PA; Lukes, AS,期刊：Drug safety, 页码：275-282 , 文章类型： Review，,卷期：2008年31-4] The first part of this benefit-risk review examined the efficacy and adverse effect profiles of systemic haemostatic agents commonly used in major surgery. The second part of this review examines the efficacy and adverse... Propofol infusion syndrome - An overview of a perplexing disease [作者：Fodale, V; La Monaca, E,期刊：Drug safety, 页码：293-303 , 文章类型： Review，,卷期：2008年31-4] Propofol (2, 6-diisopropylphenol) is a potent intravenous hypnotic agent that is widely used in adults and children for sedation and the induction and maintenance of anaesthesia. Propofol has gained popularity for its ra... Dysglycaemias and fluoroquinolones [作者：Lewis, RJ; Mohr, JF,期刊：Drug safety, 页码：283-292 , 文章类型： Review，,卷期：2008年31-4] The fluoroquinolones are an extremely popular class of antibacterials, owing to their broad spectrum of activity and the convenience of their intravenous and oral dosage formulations. Overall, the currently available flu...